Fly News Breaks for March 12, 2015
VRX, SLXP, ENDP
Mar 12, 2015 | 07:57 EDT
Canaccord believes the Valeant (VRX) bid for Salix (SLXP) is superior to Endo's (ENDO) offer because the price is fixed, versus Endo's combination of cash and stock, which could lead to a lower final price. Also, Endo does not have committed financing yet, where Valeant's bid is fully financed. Canaccord maintained its Buy rating and $104 price target on Endo.
News For ENDP;SLXP;VRX From the Last 2 Days
There are no results for your query ENDP;SLXP;VRX